This is unpublished

EDEN-EPO Dosing for Anemia in End-Stage Kidney Disease

Completed Studies
CKD
Pinned
Principal Investigator
Jonathan Himmelfarb
Funding Agency
NIH
Status
Completed

Investigator

Jonathan Himmelfarb, MD

What is the EDEN-EPO Study?

The goal of this study was to improve existing EPO dosing algorithms, with the hope that this will lead to a more personalized and accurate dosing of EPO in people with end-stage renal disease.